back to cluster viewer
cluster path 110001010
99 words, 132,695 tokens
freq alpha suffix
Words in frequency order
1 | ± | 82,811
|
2 | +/- | 49,673
|
3 | +or- | 34
|
4 | +- | 20
|
5 | -/+ | 20
|
6 | a+/- | 9
|
7 | +/– | 6
|
8 | difference= | 6
|
9 | age= | 4
|
10 | +_ | 3
|
11 | mg/hct | 3
|
12 | mg/lng | 3
|
13 | mg/m2q | 3
|
14 | mg/mpa | 3
|
15 | pmol/l-sensitivity | 3
|
16 | °c/ph | 3
|
17 | 9± | 2
|
18 | alpha-bromo | 2
|
19 | alpha-chloro | 2
|
20 | gy/20 | 2
|
21 | mg/chlorthalidone | 2
|
22 | mg/levonorgestrel | 2
|
23 | plus-or-minus | 2
|
24 | years+/-se | 2
|
25 | +2- | 1
|
26 | -/+9.9 | 1
|
27 | 0.76+/-se | 1
|
28 | 000-99 | 1
|
29 | 185-20 | 1
|
30 | 1± | 1
|
31 | 212-76 | 1
|
32 | 264-62 | 1
|
33 | 27.5- | 1
|
34 | 30.3±8.4 | 1
|
35 | 30.4±9.8 | 1
|
36 | 358/269 | 1
|
37 | 3±0.005 | 1
|
38 | 3±0.008 | 1
|
39 | 467/238 | 1
|
40 | 47.2+/- | 1
|
41 | 49.5+/- | 1
|
42 | 7+/- | 1
|
43 | 7-1.103 | 1
|
44 | 71±sd | 1
|
45 | 775-72 | 1
|
46 | 909±31 | 1
|
47 | 937.01±13 | 1
|
48 | 973-90 | 1
|
49 | 978-29 | 1
|
50 | _+ | 1
|
51 | age=68.5+/- | 1
|
52 | age±s.d.= | 1
|
53 | alpha-iodo | 1
|
54 | and61.9 | 1
|
55 | auc3-10 | 1
|
56 | cge/10 | 1
|
57 | cge/15 | 1
|
58 | days/without | 1
|
59 | efwas | 1
|
60 | g/clavulanate | 1
|
61 | groundspeed | 1
|
62 | gy/29 | 1
|
63 | h-gnrh-16 | 1
|
64 | mcg/ee | 1
|
65 | mg/10.2 | 1
|
66 | mg/17β-estradiol | 1
|
67 | mg/m²+g-csf | 1
|
68 | mg/tadalafil | 1
|
69 | ml+ropivacaine | 1
|
70 | ml+sufentanil | 1
|
71 | ml/edv-t2 | 1
|
72 | mmol/l· | 1
|
73 | months-a | 1
|
74 | months-approximately | 1
|
75 | ms/1158.7 | 1
|
76 | ms/1180.6 | 1
|
77 | mumol/l+/-0.5 | 1
|
78 | muscae | 1
|
79 | n+/- | 1
|
80 | n2o/3 | 1
|
81 | n2o/3-4 | 1
|
82 | nmol/l· | 1
|
83 | nsec | 1
|
84 | post-september | 1
|
85 | staining/pigmentation | 1
|
86 | tdlp | 1
|
87 | tetracycle | 1
|
88 | traumatol | 1
|
89 | values-2 | 1
|
90 | vas-cryo | 1
|
91 | vs+1.2 | 1
|
92 | vs.+ | 1
|
93 | vs.- | 1
|
94 | vs.. | 1
|
95 | x≤ | 1
|
96 | years+17 | 1
|
97 | years±18.6 | 1
|
98 | и | 1
|
99 | €m | 1
|
Words in alphabetical order
1 | +- | 20
|
2 | +/- | 49,673
|
3 | +/– | 6
|
4 | +2- | 1
|
5 | +_ | 3
|
6 | +or- | 34
|
7 | -/+ | 20
|
8 | -/+9.9 | 1
|
9 | 0.76+/-se | 1
|
10 | 000-99 | 1
|
11 | 185-20 | 1
|
12 | 1± | 1
|
13 | 212-76 | 1
|
14 | 264-62 | 1
|
15 | 27.5- | 1
|
16 | 30.3±8.4 | 1
|
17 | 30.4±9.8 | 1
|
18 | 358/269 | 1
|
19 | 3±0.005 | 1
|
20 | 3±0.008 | 1
|
21 | 467/238 | 1
|
22 | 47.2+/- | 1
|
23 | 49.5+/- | 1
|
24 | 7+/- | 1
|
25 | 7-1.103 | 1
|
26 | 71±sd | 1
|
27 | 775-72 | 1
|
28 | 909±31 | 1
|
29 | 937.01±13 | 1
|
30 | 973-90 | 1
|
31 | 978-29 | 1
|
32 | 9± | 2
|
33 | _+ | 1
|
34 | a+/- | 9
|
35 | age= | 4
|
36 | age=68.5+/- | 1
|
37 | age±s.d.= | 1
|
38 | alpha-bromo | 2
|
39 | alpha-chloro | 2
|
40 | alpha-iodo | 1
|
41 | and61.9 | 1
|
42 | auc3-10 | 1
|
43 | cge/10 | 1
|
44 | cge/15 | 1
|
45 | days/without | 1
|
46 | difference= | 6
|
47 | efwas | 1
|
48 | g/clavulanate | 1
|
49 | groundspeed | 1
|
50 | gy/20 | 2
|
51 | gy/29 | 1
|
52 | h-gnrh-16 | 1
|
53 | mcg/ee | 1
|
54 | mg/10.2 | 1
|
55 | mg/17β-estradiol | 1
|
56 | mg/chlorthalidone | 2
|
57 | mg/hct | 3
|
58 | mg/levonorgestrel | 2
|
59 | mg/lng | 3
|
60 | mg/m2q | 3
|
61 | mg/mpa | 3
|
62 | mg/m²+g-csf | 1
|
63 | mg/tadalafil | 1
|
64 | ml+ropivacaine | 1
|
65 | ml+sufentanil | 1
|
66 | ml/edv-t2 | 1
|
67 | mmol/l· | 1
|
68 | months-a | 1
|
69 | months-approximately | 1
|
70 | ms/1158.7 | 1
|
71 | ms/1180.6 | 1
|
72 | mumol/l+/-0.5 | 1
|
73 | muscae | 1
|
74 | n+/- | 1
|
75 | n2o/3 | 1
|
76 | n2o/3-4 | 1
|
77 | nmol/l· | 1
|
78 | nsec | 1
|
79 | plus-or-minus | 2
|
80 | pmol/l-sensitivity | 3
|
81 | post-september | 1
|
82 | staining/pigmentation | 1
|
83 | tdlp | 1
|
84 | tetracycle | 1
|
85 | traumatol | 1
|
86 | values-2 | 1
|
87 | vas-cryo | 1
|
88 | vs+1.2 | 1
|
89 | vs.+ | 1
|
90 | vs.- | 1
|
91 | vs.. | 1
|
92 | x≤ | 1
|
93 | years+/-se | 2
|
94 | years+17 | 1
|
95 | years±18.6 | 1
|
96 | °c/ph | 3
|
97 | ± | 82,811
|
98 | и | 1
|
99 | €m | 1
|
Words in suffix order
1 | vs.+ | 1
|
2 | -/+ | 20
|
3 | _+ | 1
|
4 | +- | 20
|
5 | vs.- | 1
|
6 | +/- | 49,673
|
7 | 47.2+/- | 1
|
8 | age=68.5+/- | 1
|
9 | 49.5+/- | 1
|
10 | 7+/- | 1
|
11 | a+/- | 9
|
12 | n+/- | 1
|
13 | +2- | 1
|
14 | 27.5- | 1
|
15 | +or- | 34
|
16 | vs.. | 1
|
17 | auc3-10 | 1
|
18 | cge/10 | 1
|
19 | 185-20 | 1
|
20 | gy/20 | 2
|
21 | 973-90 | 1
|
22 | 909±31 | 1
|
23 | values-2 | 1
|
24 | mg/10.2 | 1
|
25 | vs+1.2 | 1
|
26 | 264-62 | 1
|
27 | 775-72 | 1
|
28 | ml/edv-t2 | 1
|
29 | n2o/3 | 1
|
30 | 7-1.103 | 1
|
31 | 937.01±13 | 1
|
32 | n2o/3-4 | 1
|
33 | 30.3±8.4 | 1
|
34 | mumol/l+/-0.5 | 1
|
35 | 3±0.005 | 1
|
36 | cge/15 | 1
|
37 | ms/1180.6 | 1
|
38 | years±18.6 | 1
|
39 | h-gnrh-16 | 1
|
40 | 212-76 | 1
|
41 | ms/1158.7 | 1
|
42 | years+17 | 1
|
43 | 30.4±9.8 | 1
|
44 | 3±0.008 | 1
|
45 | 467/238 | 1
|
46 | and61.9 | 1
|
47 | -/+9.9 | 1
|
48 | 978-29 | 1
|
49 | gy/29 | 1
|
50 | 358/269 | 1
|
51 | 000-99 | 1
|
52 | age±s.d.= | 1
|
53 | difference= | 6
|
54 | age= | 4
|
55 | +_ | 3
|
56 | months-a | 1
|
57 | mg/mpa | 3
|
58 | nsec | 1
|
59 | groundspeed | 1
|
60 | 71±sd | 1
|
61 | muscae | 1
|
62 | mcg/ee | 1
|
63 | tetracycle | 1
|
64 | ml+ropivacaine | 1
|
65 | mg/chlorthalidone | 2
|
66 | 0.76+/-se | 1
|
67 | years+/-se | 2
|
68 | g/clavulanate | 1
|
69 | mg/m²+g-csf | 1
|
70 | mg/lng | 3
|
71 | °c/ph | 3
|
72 | mg/levonorgestrel | 2
|
73 | mg/tadalafil | 1
|
74 | ml+sufentanil | 1
|
75 | mg/17β-estradiol | 1
|
76 | traumatol | 1
|
77 | €m | 1
|
78 | staining/pigmentation | 1
|
79 | alpha-iodo | 1
|
80 | alpha-bromo | 2
|
81 | alpha-chloro | 2
|
82 | vas-cryo | 1
|
83 | tdlp | 1
|
84 | mg/m2q | 3
|
85 | post-september | 1
|
86 | efwas | 1
|
87 | plus-or-minus | 2
|
88 | mg/hct | 3
|
89 | days/without | 1
|
90 | months-approximately | 1
|
91 | pmol/l-sensitivity | 3
|
92 | +/– | 6
|
93 | x≤ | 1
|
94 | ± | 82,811
|
95 | 1± | 1
|
96 | 9± | 2
|
97 | mmol/l· | 1
|
98 | nmol/l· | 1
|
99 | и | 1
|